A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity

Karina Pino-Lagos, Yanxia Guo, Chrysothemis Brown, Matthew P. Alexander, Raúl Elgueta, Kathryn A. Bennett, Victor De Vries, Elizabeth Nowak, Rune Blomhoff, Shanthini Sockanathan, Roshantha A. Chandraratna, Ethan Dmitrovsky, Randolph J. Noelle

    Research output: Contribution to journalArticlepeer-review

    106 Citations (Scopus)
    1583 Downloads (Pure)

    Abstract

    It is known that vitamin A and its metabolite, retinoic acid (RA), are essential for host defense. However, the mechanisms for how RA controls inflammation are incompletely understood. The findings presented in this study show that RA signaling occurs concurrent with the development of inflammation. In models of vaccination and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporally and spatially restricted to the site of inflammation. Conditional ablation of RA signaling in T cells significantly interferes with CD4(+) T cell effector function, migration, and polarity. These findings provide a new perspective of the role of RA as a mediator directly controlling CD4(+) T cell differentiation and immunity.
    Original languageEnglish
    Pages (from-to)1767-1775
    Number of pages9
    JournalJournal of Experimental Medicine
    Volume208
    Issue number9
    DOIs
    Publication statusPublished - 29 Aug 2011

    Fingerprint

    Dive into the research topics of 'A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity'. Together they form a unique fingerprint.

    Cite this